Mark Johnson joins The RSA Group as Partner
London, UK, 6th February 2019 – The RSA Group, a leading Life Sciences executive search firm, announced today that Mark Johnson has joined the company as a Partner. Mark is a respected Life Sciences search professional with particular expertise in the cell and gene therapy sector.
Mark has significant experience across medical, manufacturing and supply chain, commercial, R&D, CMC, Clinical Operations, Regulatory and Programme / Project Leader recruitment. This stems from an early career in biologics development, manufacturing and quality at MedImmune and Novartis. Most recently he has focused on cell and gene therapy and joins The RSA Group as an expert in this field.
Nick Stephens, Executive Chairman of The RSA Group, commented: “I am delighted to welcome Mark to the RSA team, bringing a wealth of experience building leadership teams across the biotech and pharmaceutical industries globally.”
Mark Johnson added “I’m very pleased to join The RSA Group and look forward to working closely with the team to connect our global clients with the best talent from both the cell and gene therapy sector, and across the Life Sciences industry.”06